Richard A. Geise

RADIATION DOSE IN INTERVENTIONAL FLUOROSCOPIC PROCEDURES

Vascular interventional procedures carried out under fluoroscopic guidance often involve high radiation doses. Above certain thresholds, radiation can cause significant damage to the skin including hair loss and severe necrosis. Such damage has been reported by several investigators. Many attempts have been made to quantitate the radiation doses to the skin involved with these procedures, but dosimetry methods are often flawed. To improve the situation better monitoring of radiation doses, fluoroscopist education, and changes in technology and methods are needed.

The potential for radiation‐induced skin damage in interventional neuroradiological procedures: A review of 522 cases using automated dosimetry

The Food and Drug Administration (FDA) has recommended the monitoring of radiation skin dose to patients during procedures having the potential for radiation damage. Radiologists need information about typical radiation doses during interventional procedures. The skin doses to patients during 522 interventional neuroradiological procedures have been monitored using an automated dosimetry system. Estimated entrance skin doses (ESD) were binned into 0.5 Gy increments and compared to FDA recommended thresholds for inclusion in the patient record. Percentages of procedures exceeding the above mentioned thresholds are presented. In addition, the percentage of dose in each view and the percentage of dose in fluoroscopic and digital angiographic modes are shown. Six percent of embolization procedures and one percent of cerebral angiograms are estimated to have potential for main erythema (ESD>6 Gy). All types of procedures have potential for temporary erythema and exceed the threshold for inclusion in the patient record (ESD> 1 Gy) at the 95% percentile. The types of procedures with most potential for skin damage also have significant percentages of dose in the digital angiographic mode. Thus, monitoring fluoroscopic time alone underestimates the potential for skin injury. On the other hand, combining the doses in the posterior-anterior and lateral views, tends to overestimate the potential for radiation injury.

Evaluation of a model-based treatment planning system for dose computations in the kilovoltage energy range.

The ability to determine dose distribution and calculate organ doses from diagnostic x rays has become increasingly important in recent years because of relatively high doses in interventional radiology and cardiology procedures. In an attempt to determine the dose from both diagnostic and orthovoltage x rays, we have used a commercial treatment planning system (Pinnacle, ADAC Laboratories, Milpitas, CA) to calculate the doses in phantoms from kilovoltage x rays. The planning systems capabilities for dose computation have been extended to lower energies by the addition of energy deposition kernels in the 20-110 keV range and modeling of the 60, 80, 100, and 120 kVp beams using the system. We compared the dose calculated by the system with that measured using thermoluminescent dosimeters (TLDs) placed in various positions within several phantoms. The phantoms consisted of a cubical solid water phantom, the solid water phantom with added lung and bone inhomogeneities, and the Rando anthropomorphic phantom. Using Pinnacle, a treatment plan was generated using CT scans of each of these phantoms and point doses at the positions of TLD chips were calculated. Comparisons of measured and computed values show an average difference of less than 2% within materials of atomic number less than and equal to that of water. The algorithm, however, does not produce accurate results in and around bone inhomogeneities and underestimates attenuation of x rays by bone by an average of 145%. A modification to the CT number-to-density conversion table used by the system resulted in significant improvements in the dose calculated to points beyond bone.

Radiation doses during pediatric radiofrequency catheter ablation procedures.

Because RF catheter ablation procedures may be lengthy and are commonly performed in young patients, concern has arisen about radiation dose in this group of patients. This article investigates radiation doses in pediatric patients undergoing RF catheter ablation. Standard fluoroscopic equipment used for diagnostic electrophysiological catheterization studies is technologically capable of dose rates as high as 90 milligray (mGy) per minute to skin and adjacent lung and 260 mGy/min to vertebral bone. Dose rates of this magnitude when used for extended periods of time have been known to cause erythema, pneumonitis, and retardation of bone growth. We measured skin dose rates of nine pediatric patients undergoing RF catheter ablation for tachycardia and calculated doses to the skin using standard dosimetric methods. Fluoroscopic techniques and equipment were studied using a patient simulating phantom. Overlap of fluoroscopic fields was checked using radiotherapy portal verification film, and regions in which doses overlapped from multiple angle exposures were verified using a treatment planning computer. Patient skin dose rates ranged from 6.2–49 mGy/min for patients ranging in age from 2–20 years. Maximum skin doses ranged from 0.09–2.35 Gy. Our data demonstrate the need to directly measure dose rates for individual fluoroscopic equipment and procedural techniques in order to determine whether limitations need to be set for procedural times.

Suitability of laser stimulated TLD arrays as patient dose monitors in high dose x-ray imaging

Skin entrance doses of patients undergoing interventional x-ray procedures are capable of causing skin damage and should be monitored routinely. Single TLD chips are not suitable because the location of maximum skin exposure cannot be predicted. Most photographic films are too sensitive at diagnostic x-ray energies for dosimetry, exhibit temporal changes in response, and require special packaging by the user. We have investigated the suitability of laser heated MgB4O7 TLDs in a polyimide binder in the range of 0.2-20 Gy. These are available in radioluscent arrays up to 30 x 30 cm for direct measurement of patient skin dose. Dose response was compared with a calibrated ion chamber dosimeter. Exposures were made at 60, 90, and 120 kVp, at low (fluoroscopy) and high (DSA) dose rates, and at different beam incidence angles. Longitudinal reproducibility and response to temperature changes during exposure were also checked. The dose response is linear below approximately 6 Gy where the slope starts to increase 2% per Gy. Errors were less than +/- 2% over a 0-80 degrees range of beam incidence angles; less than +/- 3% for both dose rate variations and kVp differences between 70 and 120 kVp. The response was unaffected by temperature changes between 20 and 37 degrees C. Reproducibility is current +/- 7%. MgB4O7 TLD arrays are suitable for patient dosimetry in high dose fluoroscopy procedures if appropriate calibrations are used. Uncertainty in skin dose measurement is less than 10%, which is substantially better than film dosimetry.

Lung dose calculations at kilovoltage x-ray energies using a model-based treatment planning system.

The determination of the dose to organs from diagnostic x rays has become important because of reports of radiation injury to patients from fluoroscopically guided interventional procedures. We have modified a convolution/superposition-based treatment planning system to compute the dose distribution for kilovoltage beams. We computed lung doses using this system and compared them to those calculated using the CDI3 organ dose calculation program. We also computed average lung doses from a simulated radiofrequency ablation procedure and compared our results to published doses for a similar procedure. Doses calculated using this system were an average of 20% lower for AP beams and 7% higher for PA beams than those obtained using CDI3. The ratio of the average dose to the lungs to the skin dose from the simulated ablation procedure ranged from 25% higher to 15% lower than that determined by other authors. Our results show that a treatment planning system designed for use in the megavoltage energy range can be used for calculating organ doses in the diagnostic energy range. Our doses compare well with those previously reported. Differences are partly due to variations in experimental techniques. Using a three-dimensional (3-D) treatment planning system to calculate dose also allows us to generate dose volume histograms (DVH) and compute normal tissue complication probabilities (NTCP) for diagnostic procedures.

Measurement of the dose deposition characteristics of x-ray fluoroscopy beams in water

The purpose of this study was to characterize the x-ray dose distribution of fluoroscopy beams by measuring their percent depth dose curves and lateral dose profiles in a water phantom. Percent depth dose curves were measured near the surface with an Attix parallel plate chamber and deep within the water phantom with a Farmer-type cylindrical chamber. Percent depth dose curves were compared to published data where applicable. Lateral dose profiles were measured at depths of 2, 5, 10, and 15 cm in phantom with a Farmer chamber. Pulsed, 50 mA x-ray beams with peak tube potentials of 60, 80, 100, and 120 kV and half value layers of 1.89, 2.52, 3.20, and 4.09 mm Al, respectively, were investigated.

Routine quality control tests for film-screen mammographic systems with automatic exposure control.

Quality control of the contrast and density of mammograms is of extreme importance not only because of patient dose considerations but also because of the need to monitor changes in the breast over extended periods of time. A phantom and test technique has been developed and used at two institutions for monitoring the ability of mammographic generators and phototiming systems to provide consistent contrast and density. The phantom consists of a solid acrylic block and an embedded aluminum step wedge designed specially for low kVp use. Optical densities of various portions of the phantom are used to determine constancy of density and contrast. By minimizing fluctuations due to processing and film handling, normal variations were reduced enough to determine changes in contrast and density due to generator and phototimer changes equivalent to those monitored in processor quality control programs. The data have been correlated with changes in processor function. Changes in density and contrast values have also been related to phototimer malfunction and reduced image quality.

Establishing a quality control program for an automated dosimetry system.

Automatic dosimetry systems can provide instantaneous dose and dose-rate information during fluoroscopic procedures as well as long-term records of patient doses. For this information to be useful, it is necessary that the accuracy of such systems be maintained through a rigorous quality control program. Daily and weekly quality control checks were performed on a PEMNET automated dosimetry system to determine its stability and the value of such tests in a quality control program. Weekly tests included monitoring the accuracy of the measured doses under a variety of conditions. The results of the tests indicate possible improvements in test methodology and real and potential sources of system failure and provide a statistical basis for setting quality control limits for future system monitoring.

Lung dose calculations at fluoroscopic X-ray energies using a model-based treatment planning system

Accurate determination of the dose to various organs from diagnostic X-rays has become increasingly important in recent years because of incidents of radiation injury to patients undergoing certain interventional fluoroscopically-guided procedures. We have modified a convolution/superposition-based treatment planning system (ADAC Pinnacle) and used it to determine the dose distribution within the body from kilovoltage X-rays and computed the lung dose from them. We compared the average lung doses calculated by the planning system to those of a widely used organ dose calculation program (CDI3) for 32 different field sizes and orientations using a standard man phantom. We then used the system to compute average lung doses from a simulated ablation procedure and compared our results to published doses for similar procedures. Doses calculated using Pinnacle were an average of 20% lower for AP beams and 10% higher for PA beams than those obtained using CDI3. The ratio of the average dose to the lungs to the skin dose from the simulated ablation procedure ranged from 15% higher to 30% lower than that estimated by other authors. In conclusion, our results show that a treatment planning system can be a viable tool to calculate organ doses in the diagnostic energy range. There are differences between our results and those obtained by other methods which can be partly explained by the variations among the different methods.